Adult Prevention of VTE: Orthopaedic & abdominal surgery 2.5 mg SC once daily for 5-9 days, administered 6 hr following surgical closure provided haemostasis has been established.
Medical patient at risk of thromboembolic complications 2.5 mg SC once daily for 6-14 days.
Unstable angina/non-ST segment elevation MI 2.5 mg SC initiated as soon as possible following diagnosis & continued for up to 8 days or until hospital discharge.
ST segment elevation MI 2.5 mg once daily w/ 1st dose administered IV & subsequent doses administered SC. Initiate treatment as soon as possible following diagnosis & continued for up to 8 days or until hospital discharge.
DVT & PE >100 kg 10 mg SC once daily,
50-100 kg 7.5 mg SC once daily,
<50 kg 5 mg SC once daily. Continue treatment for at least 5 days & until adequate oral anticoagulation is established.